Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implants in Patients with Chronic Retinal Degenerative Diseases

2012187 citationsJournal Articlebronze Open Access

Authors

Konrad Kauper · Neurotech (United States)

C. McGovern

Abstract

This retrospective study demonstrated that the intraocular ECT implant has a favorable pharmacokinetic profile for the treatment of chronic retinal degenerative diseases without systemic exposure. (ClinicalTrials.gov numbers, NCT00063765, NCT00447954, NCT00447980, NCT00447993.).

Topics & Keywords

Retinal Development and Disorders Retinal and Macular Surgery Retinal Diseases and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Investigative Ophthalmology & Visual Science

Volume 53, Issue 12, pp. 7484-7484

DOI: 10.1167/iovs.12-9970

Field-Weighted Citation Impact: 6.04